The Smallest Worthwhile Effect as an Alternative to MCID for Adult Scoliosis
The Smallest Worthwhile Effect as an Alternative to MCID for Adult Scoliosis
To unlock this feature and to subscribe to our weekly evidence emails, please create a FREE OrthoEvidence account
Already have an account? Click hereThe episode opens with reflections on early mornings, coffee rituals, and fall sports before shifting to a detailed discussion on patient-reported outcome measures. The hosts examine a new study introducing the “smallest worthwhile effect” (SWE) as an alternative to traditional MCID thresholds in adult idiopathic scoliosis surgery. They outline how SWE incorporates patient-anchored benefits, risks, and costs, contrasting this with anchor-based and distribution-based MCID methods and highlighting the challenges of interpreting group-level thresholds for individual patients. The conversation broadens into methodological rigor, sample-size limitations, and the growing complexity of statistical modeling in orthopaedic research, emphasizing the importance of expert review, balanced editorial decisions, and the evolution of evidence-based practice across decades.
DISCLAIMER:
This podcast is for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. If you require medical treatment, always seek the advice of your physician or go to your nearest emergency department.
The opinions, beliefs, and viewpoints expressed by the individuals on this podcast do not reflect the opinions, beliefs, and viewpoints of OrthoEvidence.
LOGIN
Join the Conversation
Please Login or Join to leave comments.